Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Mesylate”

623 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 623 results

Testing effectiveness (Phase 2)Study completedNCT01126814
What this trial is testing

Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

Who this might be right for
Leukemia
University Health Network, Toronto 35
Testing effectiveness (Phase 2)Ended earlyNCT00323063
What this trial is testing

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 49
Testing effectiveness (Phase 2)UnknownNCT00180921
What this trial is testing

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Who this might be right for
Cancer of the Head and NeckCarcinoma, Adenoid Cystic
Gustave Roussy, Cancer Campus, Grand Paris 30
Testing effectiveness (Phase 2)Ended earlyNCT00354523
What this trial is testing

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Who this might be right for
Solid TumorThyroid Cancer
M.D. Anderson Cancer Center 21
Early research (Phase 1)Active Not RecruitingNCT05245968
What this trial is testing

Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Who this might be right for
Gastrointestinal Stromal Tumors
Taiho Pharmaceutical Co., Ltd. 78
Post-approval studies (Phase 4)Study completedNCT00980018
What this trial is testing

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Study completedNCT01289028
What this trial is testing

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 125
Testing effectiveness (Phase 2)UnknownNCT00028847
What this trial is testing

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Commissie Voor Klinisch Toegepast Onderzoek 60
Testing effectiveness (Phase 2)Study completedNCT00036751
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00408460
What this trial is testing

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
University of Washington 34
Testing effectiveness (Phase 2)WithdrawnNCT02342600
What this trial is testing

SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)

Who this might be right for
Gastrointestinal Stromal Tumors
Sarcoma Alliance for Research through Collaboration
Testing effectiveness (Phase 2)Study completedNCT00677092
What this trial is testing

Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis

Who this might be right for
Nephrogenic Systemic Fibrosis
Massachusetts General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00684411
What this trial is testing

Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Who this might be right for
T Cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 12
Large-scale testing (Phase 3)Study completedNCT00981942
What this trial is testing

Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec

Who this might be right for
Nephrogenic Systemic Fibrosis
University of Aarhus 10
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01478373
What this trial is testing

Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 39
Testing effectiveness (Phase 2)Study completedNCT01097694
What this trial is testing

Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)

Who this might be right for
Asthma
Brigham and Women's Hospital 176
Large-scale testing (Phase 3)Study completedNCT00574873
What this trial is testing

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

Who this might be right for
Chronic Myeloid Leukemia
Pfizer 502
Testing effectiveness (Phase 2)UnknownNCT04709731
What this trial is testing

Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia (CML)
Associazione Italiana Pazienti Leucemia Mieloide Cronica 50
Not applicableStudy completedNCT02896829
What this trial is testing

Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
University Hospital, Bordeaux 97
Load More Results